CoChat

Erythromycin attenuates oxidative stress-induced cellular senescence via the PI3K-mTOR signaling pathway in chronic obstructive pulmonary disease

Open access
Xiaofei, Yi, Tingting, Li, Xuan, Wei, Zhiyi, He · 2022 · Frontiers in Pharmacology

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Abstract

Background and Purpose: Chronic obstructive pulmonary disease (COPD) is proposed to hasten lung aging. Erythromycin protects against oxidative stress and inflammatory responses. However, the potential anti-senescence effect of erythromycin remains disclosed. In the present study, we investigated whether erythromycin influenced oxidative stress-induced cellular senescence and investigated its related mechanisms. Methods: A cigarrete smoke (CS) -induced emphysema mouse model and a H 2 O 2-induced premature senescence model in human bronchial epithelial cell line (BEAS-2B) were established. Senescence-related markers (P53, P21 and SA-β-Gal activity), and levels of oxidative stress biomarkers (MDA, SOD and ROS) were measured. Additionally, cells were pretreated with rapamycin (mTOR inhibitor) or erythromycin, and the expression levels of components of the PI3K-mTOR signaling pathway were measured in BEAS-2B cells. Results: Exposed to H 2 O 2, increased SA-β-gal activity was observed in BEAS-2B cells suggesting premature senescence. Erythromycin inhibited the expression of P53 and P21 in the CS-induced emphysema mouse model. MDA levels significantly increased and SOD levels decreased in the CS-exposed mice and H 2 O 2-induced BEAS-2B cells. Rapamycin and erythromycin significantly suppressed the expression of P53 and P21. Additionally, rapamycin and erythromycin inhibited the PI3K-mTOR signaling pathway. Conclusion: Our findings suggest that erythromycin ameliorates oxidative stress-induced cellular senescence via the PI3K-mTOR signaling pathway. Hence, we establish a theoretical foundation for the clinical application of erythromycin for COPD prevention and treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fphar.2022.1043474

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1 MLI and IHC staining of P53 and P21 in murine lungs (A–B) Alveolar MLI. Magnification: ×200. (C–D) IHC staining of P53. Magnification: ×400. (E–F) IHC staining of P21. Magnification:×400. (G) Scatter plot of correlation analysis for mean density of P53 and P21 staining with MLI in murine lungs. ***p < 0.0001. **p < 0.001. CS, cigarrete smoke. EM,erythromycin. MLI, mean linear intercept. IHC, immunohistochemistry.
FIGURE 1 MLI and IHC staining of P53 and P21 in murine lungs (A–B) Alveolar MLI. Magnification: ×200. (C–D) IHC staining of P53. Magnification: ×400. (E–F) IHC staining of P21. Magnification:×400. (G) Scatter plot of correlation analysis for mean density of P53 and P21 staining with MLI in murine lungs. ***p < 0.0001. **p < 0.001. CS, cigarrete smoke. EM,erythromycin. MLI, mean linear intercept. IHC, immunohistochemistry.CC BY · PubMed Central
FIGURE 2 Erythromycin inhibited the expression of P53 and P21 in mice with CS-induced emphysema. (A)Protein expression levels of P53 and P21. (B‐C) mRNA expression levels of P53 and P21. ***p < 0.0001, **p < 0.001.
FIGURE 2 Erythromycin inhibited the expression of P53 and P21 in mice with CS-induced emphysema. (A)Protein expression levels of P53 and P21. (B‐C) mRNA expression levels of P53 and P21. ***p < 0.0001, **p < 0.001.CC BY · PubMed Central
FIGURE 3 Antioxidant effect of erythromycin in vivo and in vitro. (A) Fluorescence photomicrographs of different groups of BEAS-2B cells. BEAS-2B cells were treated with 100 μ M H202,10 mg/m1 erythromycin or lOnM rapamycin. (B–C) SOD and MDA levels in mice. (D–E) SOD and MDA levels in BEAS-2B cells. ***p < 0.0001, **p < 0.001, *p < 0.05. EM, erythromycin. Rapa, rapamycin.
FIGURE 3 Antioxidant effect of erythromycin in vivo and in vitro. (A) Fluorescence photomicrographs of different groups of BEAS-2B cells. BEAS-2B cells were treated with 100 μ M H202,10 mg/m1 erythromycin or lOnM rapamycin. (B–C) SOD and MDA levels in mice. (D–E) SOD and MDA levels in BEAS-2B cells. ***p < 0.0001, **p < 0.001, *p < 0.05. EM, erythromycin. Rapa, rapamycin.CC BY · PubMed Central
FIGURE 4 Effects of H202 in BEAS-2B cells. (A–B) SA- β -gal staining of BEAS-2B cells treated with different concentration of H202. Magnification: ×200. (C) Cell viability assay of BEAS-2B cells treated with different concentration of H202. (D–E) Effects of H202 on P53 and P21 protein and mRNA expression. ***p < 0.0001, **p < 0.001.
FIGURE 4 Effects of H202 in BEAS-2B cells. (A–B) SA- β -gal staining of BEAS-2B cells treated with different concentration of H202. Magnification: ×200. (C) Cell viability assay of BEAS-2B cells treated with different concentration of H202. (D–E) Effects of H202 on P53 and P21 protein and mRNA expression. ***p < 0.0001, **p < 0.001.CC BY · PubMed Central
FIGURE 5 Effects of erythromycin in H202-treated BEAS-2B cells. (A–B) SA-13-gal staining of BEAS-2B cells treated with or without erythromycin and H202. Magnification: ×200. (C) Cell viability assay of BEAS-2B cells treated with different concentrations of erythromycin. (D–E) Expression of senescence markers P53 and P21. ***p < 0.0001, **p < 0.001,*p < 0.005.
FIGURE 5 Effects of erythromycin in H202-treated BEAS-2B cells. (A–B) SA-13-gal staining of BEAS-2B cells treated with or without erythromycin and H202. Magnification: ×200. (C) Cell viability assay of BEAS-2B cells treated with different concentrations of erythromycin. (D–E) Expression of senescence markers P53 and P21. ***p < 0.0001, **p < 0.001,*p < 0.005.CC BY · PubMed Central
FIGURE 6 The PI3K-mTOR signaling pathway contributed to H202-induced cellular senescence in BEAS-2B cells. (A–B) SA-13-gal staining of BEAS-2B cells treated with or without rapamycin and H202. Magnification: ×200. (C) Cell viability assay of BEAS-2B cells treated with different concentrations of rapamycin. (D–E) Protein and mRNA levels of P53 and P21. (F) The expression level of proteins of the PI3K-mTOR pathway. **p < 0.001, *p < 0.005.
FIGURE 6 The PI3K-mTOR signaling pathway contributed to H202-induced cellular senescence in BEAS-2B cells. (A–B) SA-13-gal staining of BEAS-2B cells treated with or without rapamycin and H202. Magnification: ×200. (C) Cell viability assay of BEAS-2B cells treated with different concentrations of rapamycin. (D–E) Protein and mRNA levels of P53 and P21. (F) The expression level of proteins of the PI3K-mTOR pathway. **p < 0.001, *p < 0.005.CC BY · PubMed Central
FIGURE 7 Erythromycin inhibited H202-induced BEAS-2B cellular senescence via the PI3K-mTOR signaling pathway. The expression level of proteins of the PI3K-mTOR pathway was assessed using western blot. ***p < 0.0001, **p < 0.001,*p < 0.005.
FIGURE 7 Erythromycin inhibited H202-induced BEAS-2B cellular senescence via the PI3K-mTOR signaling pathway. The expression level of proteins of the PI3K-mTOR pathway was assessed using western blot. ***p < 0.0001, **p < 0.001,*p < 0.005.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 42 references

Cited by

See all 33

Metadata

Authors
Xiaofei, Y., Tingting, L., Xuan, W., & Zhiyi, H.
Affiliations
First Affiliated Hospital of GuangXi Medical University (CN)
Venue
Frontiers in Pharmacology
Published
2022-11-23
Volume
13
Pages
1043474-1043474
ISSN
1663-9812 (ISSN-L)
OpenAlex
W4309707240
Cited by
31
References
42
Citations by year
2026: 7 · 2025: 12 · 2024: 8 · 2023: 4
FWCI
3.72
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Pharmacology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Natural Science Foundation of China
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
Keywords
erythromycin, cellular senescence, oxidative stress, chronic obstructive pulmonary disease, emphysema, cigarette smoke, hydrogen peroxide, p53, p21, lung aging, bronchial epithelial cells, rapamycin, reactive oxygen species, lipid peroxidation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Erythromycin attenuates oxidative stress-induced cellular senescence via the PI3K-mTOR signaling pathway in chronic obstructive pulmonary disease. https://app.cochat.ai/papers/10.3389/fphar.2022.1043474
The paper
Xiaofei, Y., Tingting, L., Xuan, W., & Zhiyi, H. (2022). Erythromycin attenuates oxidative stress-induced cellular senescence via the PI3K-mTOR signaling pathway in chronic obstructive pulmonary disease. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2022.1043474

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.